Affinity Asset Advisors »

Alto Neuroscience shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $11M 500k 22.48

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Alto Neuroscience

Falcon Edge Capital
Commodore Capital
Vestal Point Capital
Perceptive Advisors
Vanguard Capital Management
Franklin Resources
Vivo Capital
Armistice Capital
Millennium Management
72 Investment Holdings
BlackRock
Susquehanna International
Ikarian Capital
Point72 Asset Management
VR Adviser

View all funds holding Alto Neuroscience